60 Degrees Pharmaceuticals, Inc. (SXTP)

CIK 0001946563 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Condensed Balance Sheets (unaudited)
—
Consolidated Balance Sheets
—
Consolidated Condensed Balance Sheets (unaudited) (P)
—
Consolidated Balance Sheets (P)
—
Consolidated Condensed Statements of Operations and Comprehensive (loss) Income (unaudited)
—
Consolidated Condensed Statements of Operations and Comprehensive Income (loss) (unaudited)
—
Consolidated Condensed Statements of Operations and Comprehensive Loss (unaudited)
—
Consolidated Condensed Statements of Operations and Comprehensive Income (loss) (unaudited) (P)
—
Consolidated Condensed Statements of Operations and Comprehensive Loss (unaudited) (P)
—
Consolidated Condensed Statements of Shareholders Equity (deficit) (unaudited)
—
Consolidated Condensed Statements of Shareholders' Equity (unaudited)
—
Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Condensed Statements of Shareholders and Members Deficit (unaudited)
—
Consolidated Condensed Statements of Shareholders and Members Equity (deficit) (unaudited)
—
Consolidated Condensed Statements of Shareholders Equity (deficit) (unaudited) (P)
—
Consolidated Condensed Statements of Shareholders' Equity (unaudited) (P)
—
Consolidated Statements of Operations and Comprehensive Loss (P)
—
Consolidated Statements of Shareholders' Equity
—
Consolidated Condensed Statements of Cash Flows (unaudited)
—
Consolidated Condensed Statements of Shareholders and Members Equity (deficit) (unaudited) (P)
—
Consolidated Statements of Shareholders and Members Equity (deficit)
—
Consolidated Statements of Shareholders' Equity (P)
—
Consolidated Condensed Statements of Cash Flows (unaudited) (P)
—
Consolidated Statements of Cash Flows
—
Consolidated Statements of Shareholders and Members Equity (deficit) (P)
—
Consolidated Statements of Cash Flows (P)
—
Notes
Capitalization and Equity Transactions
—
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Deferred Compensation
Derivative Liabilities
Income Taxes
Insider Trading Arrangements
Intangible Assets
Inventory
Nature of Operations
Pay Vs Performance Disclosure
Property and Equipment
Share-based Compensation
Stockholders' Equity
Subsequent Events
Summary of Significant Accounting Policies